Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665561 · ClinicalTrials.gov registry record
Prospective Observational Epidemiologic Study of Maraviroc's Safety
A clinical trial, sponsored by ViiV Healthcare.
- Completed
- Registry status
- 2,500
- Enrollment target
NCT00665561 is a clinical trial that has completed, run by ViiV Healthcare. The registered enrollment target is 2,500 participants.
The verdict
NCT00665561 has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.
Interventions
- DRUG Maraviroc along with an optimized background antiretroviral drug regimen
- DRUG Optimized background antiretroviral drug regimen without maraviroc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2008-03-31 |
| Est. Completion | 2019-02-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00665561
The ClinicalTrials.gov registry entry for NCT00665561 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maraviroc along with an optimized background antiretroviral drug regimen is the first listed.
NCT00665561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00665561 about?
NCT00665561 is a clinical study titled "Prospective Observational Epidemiologic Study of Maraviroc's Safety". The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.
What is the current status of trial NCT00665561?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2008-03-31. Estimated completion is 2019-02-14.
What interventions are being tested in trial NCT00665561?
The interventions under investigation include: Maraviroc along with an optimized background antiretroviral drug regimen (DRUG), Optimized background antiretroviral drug regimen without maraviroc (DRUG).
Who is sponsoring clinical trial NCT00665561?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.